Levi Sandri Giovanni Battista, de Werra Edoardo, Mascianà Gianluca, Colasanti Marco, Santoro Roberto, D'Andrea Vito, Ettorre Giuseppe Maria
Division of General Surgery and Liver Transplantation, S. Camillo Hospital, Rome, Lazio, Italy;; Department of Surgical Sciences, Sapienza University of Rome, Rome, Italy.
Division of General Surgery and Liver Transplantation, S. Camillo Hospital, Rome, Lazio, Italy.
Hepatobiliary Surg Nutr. 2016 Dec;5(6):478-484. doi: 10.21037/hbsn.2016.05.05.
Hepatocellular carcinoma (HCC) is the sixth most common malignant tumor worldwide and the most common primary liver cancer, in over 80% of cases HCC grown on a cirrhotic liver. Laparoscopic liver resection (LLR) is now worldwide accepted considering the excellent results shown. Minimally invasive surgical approach for HCC is increasing continuously and in specialized centers seems to become the first-line approach for those patients. The aim of this review presents and discusses state of the art in the laparoscopic and robotic surgical treatment of HCC. An electronic search was performed to identify all studies dealing with HCC resected with laparoscopy or robotic approach. Indications for laparoscopic resection, robotic assisted and totally robotic resection of HCC will be doubtless increased in future years. LLR and robotic approach for HCC is safe and feasible.
肝细胞癌（HCC）是全球第六大常见恶性肿瘤，也是最常见的原发性肝癌，超过80%的病例中HCC生长于肝硬化肝脏。鉴于已显示出的出色结果，腹腔镜肝切除术（LLR）目前已被全球接受。HCC的微创外科手术方法在不断增加，在专业中心似乎已成为这些患者的一线治疗方法。本综述的目的是介绍和讨论HCC腹腔镜和机器人手术治疗的最新进展。进行了电子检索以识别所有涉及通过腹腔镜或机器人手术方法切除HCC的研究。未来几年，HCC腹腔镜切除、机器人辅助和全机器人切除的适应证无疑会增加。HCC的LLR和机器人手术方法是安全可行的。
